Blog

Mark Humayun featured on NBC News for inventions to treat blindness

By Alexandra Demetriou Mark Humayun, MD, PhD, recently appeared on NBC California Live in a feature highlighting the remarkable story of his patient, Anna Kuehl, who regained her eyesight thanks to a retinal implant invented by Humayun’s research team. Anna, a mother of two living in Southern California with her husband, noticed that her vision […]

Dr. Humayun featured on Walter Isaacson’s Trailblazers podcast

 By Alexandra Demetriou Mark Humayun, MD, PhD, was recently featured on Trailblazers, an original podcast hosted by former CNN chairman and CEO Walter Isaacson. The Trailblazers podcast features leaders across society who have shaken up their fields, innovated in ways many would think impossible and charged forward to pioneer changes that excite the way […]

USC research coalition uses computer models to accelerate advancements in vision science

By Alexandra Demetriou The Argus II retinal prosthesis––often referred to as the world’s first “bionic eye” ––revolutionized the treatment of blindness. Throughout the past decade, this artificial retina, developed by Mark Humayun, MD, PhD and colleagues in collaboration with Second Sight Medical Products, has enabled hundreds of patients around the world with complete retinal blindness […]

Stanford study ranks Mark Humayun, MD, PhD on world’s top scientists list

By Alexandra Demetriou Mark Humayun, MD, PhD, was included in a recent analysis out of Stanford University highlighting the world’s leading scientists across 22 fields of research and 176 sub-fields. Within the category of “ophthalmology & optometry,” Humayun ranks among the top 0.2% of his peers. The rankings were calculated based on metrics such as […]

USC Ginsburg Institute for Biomedical Therapeutics Awards Inaugural Mordechai “Mort” Arditti Award for Excellence

By Alexandra Demetriou On November 20th, 2020, the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics awarded its inaugural Mordechai “Mort” Arditti Award for Excellence to Alejandra Gonzalez-Calle, PhD, a postdoctoral researcher working to develop vision science innovations at the USC Ginsburg Institute. Gonzalez-Calle grew up in Medellín, Colombia, and earned a BS […]

USC Ginsburg Institute to host first-of-its-kind symposium on biomedical engineering in ophthalmology

By Alexandra Demetriou The USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics recently received support from the National Eye Institute to host a first-of-its-kind symposium on the use of implantable and wearable devices in ophthalmology. The symposium, called “Abiotic-Biotic Interfaces for Ophthalmology,” will bring together world experts in clinical care, biomedical research, engineering, […]

USC Ginsburg Institute researchers help lead development of precision drug delivery tool to treat traumatic brain injury

By Alexandra Demetriou An interdisciplinary team of researchers at the University of Southern California has developed a precision drug delivery tool to selectively treat areas of the brain damaged during a traumatic brain injury (TBI). The researchers anticipate that their rapidly deployable intervention could potentially help prevent long-term brain damage in the millions of Americans […]

Mark Humayun, MD, PhD Receives 25th Annual Gertrude D. Pyron Award

By Alexandra Demetriou Mark Humayun, MD, PhD was recently awarded the Retina Research Foundation’s 25th Annual Gertrude D. Pyron Award. According to the Retina Research Foundation, this honor is bestowed upon “outstanding vision scientists whose work contributes to knowledge about vitreoretinal disease.” Humayun, a prolific inventor, is widely recognized for his substantial and lasting contributions […]

USC researchers bioengineer first-line defense against COVID-19

By Alexandra Demetriou Researchers at the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics, the USC Institute for Technology and Medical Systems and the USC School of Pharmacy are developing an antimicrobial fluid to bolster the body’s first-line defenses against COVID-19. The biocompatible coating is intended to block the virus from entering the […]